824 related articles for article (PubMed ID: 27531618)
1. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC
Expert Rev Clin Immunol; 2016 Oct; 12(10):1015-26. PubMed ID: 27531618
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
[TBL] [Abstract][Full Text] [Related]
5. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasound examination of hidradenitis suppurativa].
Martorell A; Segura Palacios JM
Actas Dermosifiliogr; 2015 Nov; 106 Suppl 1():49-59. PubMed ID: 26895939
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
Bassas-Vila J; González Lama Y
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.
Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077114
[TBL] [Abstract][Full Text] [Related]
10. Secukinumab in the treatment of hidradenitis suppurativa.
Snyder CL; Gibson RS; Porter ML; Kimball AB
Immunotherapy; 2023 Dec; 15(17):1449-1457. PubMed ID: 37840286
[TBL] [Abstract][Full Text] [Related]
11. Biologics for hidradenitis suppurativa: an update.
Włodarek K; Ponikowska M; Matusiak Ł; Szepietowski JC
Immunotherapy; 2019 Jan; 11(1):45-59. PubMed ID: 30702012
[TBL] [Abstract][Full Text] [Related]
12. Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.
Zouboulis CC; Okun MM; Prens EP; Gniadecki R; Foley PA; Lynde C; Weisman J; Gu Y; Williams DA; Jemec GBE
J Am Acad Dermatol; 2019 Jan; 80(1):60-69.e2. PubMed ID: 29860040
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae.
von Laffert M; Stadie V; Wohlrab J; Marsch WC
Br J Dermatol; 2011 Feb; 164(2):367-71. PubMed ID: 20831631
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab: A Review in Hidradenitis Suppurativa.
Kim ES; Garnock-Jones KP; Keam SJ
Am J Clin Dermatol; 2016 Oct; 17(5):545-552. PubMed ID: 27665300
[TBL] [Abstract][Full Text] [Related]
15. LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.
Tchernev G
Georgian Med News; 2023; (340-341):297-300. PubMed ID: 37805915
[TBL] [Abstract][Full Text] [Related]
16. Update on Hidradenitis Suppurative (Part II): Treatment.
Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
Moyano B; Clemente A; Marín-Jiménez I; Martorell A
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
[TBL] [Abstract][Full Text] [Related]
18. [CME Dermatology 23: Hidradenitis suppurativa].
Dahmen RA; Lautenschlager S
Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
[TBL] [Abstract][Full Text] [Related]
19. [Treatment options in severe hidradenitis suppurativa].
Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa.
Tzanetakou V; Stergianou D; Giamarellos-Bourboulis EJ
Expert Opin Drug Saf; 2020 Apr; 19(4):381-393. PubMed ID: 32098513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
